SCHEMBL11922650

SCHEMBL11922650

c1cc(N2CCCC2)cnn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.58
CHRNB2 P17787 3/20 0.43
CHRNA4 P43681 3/20 0.43
MAPT P10636 2/20 0.41
HRH4 Q9H3N8 1/20 0.40
TERT O14746 2/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30837612 1.00 CHKA (0.58) CHKACHRNB2CHRNA4MAPTHRH4
SCHEMBL18136307 0.98 CHKA (0.56) CHKACHRNB2CHRNA4MAPTHRH4
SCHEMBL10491585 0.98 CHKA (0.56) CHKACHRNB2CHRNA4MAPTHRH4
SCHEMBL30750948 0.95 CHKA (0.52) CHKACHRNB2CHRNA4MAPTHRH4
SCHEMBL18136308 0.83 HRH4 (0.50) CHKAMAPTHRH4ALDH1A1KDM4E
SCHEMBL2103156 0.83 CHKA (0.39) CHKACHRNB2CHRNA4MAPTADRB2
SCHEMBL18136305 0.81 LMNA (0.50) CHKAMAPTALDH1A1KDM4EMEN1
SCHEMBL194631 0.81 PLD1 (0.62) CHRNB2CHRNA4ADRB2NCF1PLD1
SCHEMBL9557411 0.81 CHKA (0.38) CHKACHRNB2CHRNA4MAPTHRH4
SCHEMBL9557417 0.81 HRH4 (0.47) MAPTHRH4ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061813-A1 PYRROLIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2022-09-28 EP disclosed
CN-104903320-B Nitrogen-containing heterocycle compound or its salt 富士胶片株式会社 2018-11-13 CN disclosed
US-9469706-B2 Polymers functionalized with unsaturated heterocycles containing a protected amino group BRIDGESTONE CORPORATION (JP) 2016-10-18 US disclosed
US-8575156-B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2013-11-05 US disclosed
US-8242111-B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2012-08-14 US disclosed
US-20110124635-A1 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 VITAE PHARMACEUTICALS, INC. 2011-05-26 US disclosed
US-20110015157-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 Vitae Pharmaceuticals ,Inc. 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124635-A1 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSD17B1, HSD3B1 CHKA 3548/4885CHRNB2 2571/4885CHRNA4 3013/4885
US-20110015157-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 CHKA 1896/4885CHRNB2 1809/4885CHRNA4 2901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.